• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Relationship Between Norepinephrine Equivalent Dose of Vasopressors Within 24 Hours From the Onset of Septic Shock and In-Hospital Mortality Rate.

作者信息

Sato Ryota, Duggal Abhijit, Sacha Gretchen L, Rudoni Michael A, Yataco Angel Coz, Khanna Ashish K, Dugar Siddharth

机构信息

Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH.

Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH.

出版信息

Chest. 2023 Jan;163(1):148-151. doi: 10.1016/j.chest.2022.07.018. Epub 2022 Jul 31.

DOI:10.1016/j.chest.2022.07.018
PMID:35921884
Abstract
摘要

相似文献

1
The Relationship Between Norepinephrine Equivalent Dose of Vasopressors Within 24 Hours From the Onset of Septic Shock and In-Hospital Mortality Rate.感染性休克发病后24小时内血管升压药去甲肾上腺素等效剂量与住院死亡率的关系。
Chest. 2023 Jan;163(1):148-151. doi: 10.1016/j.chest.2022.07.018. Epub 2022 Jul 31.
2
Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.作为主要血管加压药和脓毒性休克试验死亡率结局的替代指标，存活天数和无残疾天数。
J Crit Care. 2018 Oct;47:333-337. doi: 10.1016/j.jcrc.2018.05.003. Epub 2018 May 12.
3
Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.比较去甲肾上腺素、肾上腺素和苯肾上腺素的等压器剂量对脓毒性心肌功能障碍的影响。
Anesthesiology. 2012 May;116(5):1083-91. doi: 10.1097/ALN.0b013e31824f9669.
4
Effect of norepinephrine on the outcome of septic shock.去甲肾上腺素对感染性休克结局的影响。
Crit Care Med. 2000 Aug;28(8):2758-65. doi: 10.1097/00003246-200008000-00012.
5
Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.血管升压药治疗感染性休克：系统评价与Meta分析
PLoS One. 2015 Aug 3;10(8):e0129305. doi: 10.1371/journal.pone.0129305. eCollection 2015.
6
Norepinephrine Shortage Led to Increased Deaths from Septic Shock.去甲肾上腺素短缺导致感染性休克死亡人数增加。
Am J Nurs. 2017 Jul;117(7):15. doi: 10.1097/01.NAJ.0000520929.64773.4e.
7
Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.去甲肾上腺素和血管加压素与去甲肾上腺素和肾上腺素治疗脓毒性休克成人患者的比较。
Ann Pharmacother. 2019 Sep;53(9):877-885. doi: 10.1177/1060028019843664. Epub 2019 Apr 8.
8
Vasopressor weaning in patients with septic shock.感染性休克患者的血管活性药物撤机
Crit Care Nurs Clin North Am. 2014 Sep;26(3):413-25. doi: 10.1016/j.ccell.2014.04.001. Epub 2014 May 28.
9
A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.脓毒性休克升压药剂量预后预测价值的时间敏感性分析。
Anaesthesia. 2021 Oct;76(10):1358-1366. doi: 10.1111/anae.15453. Epub 2021 Mar 9.
10
Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.美国去甲肾上腺素短缺与脓毒性休克患者死亡率之间的关联。
JAMA. 2017 Apr 11;317(14):1433-1442. doi: 10.1001/jama.2017.2841.

引用本文的文献

1
Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?血管加压素及其类似物在感染性休克患者中的应用：圣杯还是未兑现的承诺？
Crit Care. 2025 Jul 29;29(1):333. doi: 10.1186/s13054-025-05540-2.
2
Angiotensin II, conventional vasopressor therapy, and mortality in shock: a large, multicenter, propensity score-weighted analysis.血管紧张素II、传统血管升压药治疗与休克死亡率：一项大型多中心倾向评分加权分析
Ann Intensive Care. 2025 Jul 23;15(1):104. doi: 10.1186/s13613-025-01522-3.
3
Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery.
心脏手术后血管麻痹患者血管紧张素 II 给药时机与预后的关系。
JTCVS Open. 2025 Apr 25;25:280-293. doi: 10.1016/j.xjon.2025.04.014. eCollection 2025 Jun.
4
Vasopressin use across shock states: international insights from an international ESICM-endorsed survey: the PRESS Survey.血管加压素在不同休克状态下的应用：一项经国际重症监护医学学会认可的国际调查——PRESS 调查的国际见解
Crit Care. 2025 Jul 3;29(1):273. doi: 10.1186/s13054-025-05505-5.
5
Ability of diastolic arterial pressure to better characterize the severity of septic shock when adjusted for heart rate and norepinephrine dose.在根据心率和去甲肾上腺素剂量进行调整后，舒张期动脉压更能准确表征感染性休克严重程度的能力。
Ann Intensive Care. 2025 Mar 26;15(1):43. doi: 10.1186/s13613-025-01454-y.
6
Haemodynamic management of septic shock.脓毒性休克的血流动力学管理
Burns Trauma. 2025 Jan 15;13:tkae081. doi: 10.1093/burnst/tkae081. eCollection 2025.
7
Sepsis-induced cardiogenic shock: controversies and evidence gaps in diagnosis and management.脓毒症诱导的心源性休克：诊断与治疗中的争议和证据空白
J Intensive Care. 2025 Jan 2;13(1):1. doi: 10.1186/s40560-024-00770-y.
8
Septic Shock Requiring Three Vasopressors: Patient Demographics and Outcomes.需要三种血管加压药的感染性休克：患者特征和结局。
Crit Care Explor. 2024 Nov 8;6(11):e1167. doi: 10.1097/CCE.0000000000001167. eCollection 2024 Nov 1.
9
The Price We Pay for Progression in Shock Care: Economic Burden, Accessibility, and Adoption of Shock-Teams and Mechanical Circulatory Support Devices.我们为休克治疗的进步付出的代价：休克团队和机械循环支持设备的经济负担、可及性和采用。
Curr Cardiol Rep. 2024 Oct;26(10):1123-1134. doi: 10.1007/s11886-024-02108-4. Epub 2024 Sep 26.
10
The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients.去甲肾上腺素剂量报告异质性对脓毒性休克患者死亡率预测的影响。
Crit Care. 2024 Jul 3;28(1):216. doi: 10.1186/s13054-024-05011-0.